What each role should evaluate
An owner should evaluate ImpetusRX on consolidation and margin. Because Ironsail markets cross-pharmacy comparison and cited average savings rather than a public pass-through per-vial catalog, the owner should compare landed cost on their top SKUs during a trial — not rely on network-wide statistics alone. They should also weigh the cost and disruption of migrating charting into ImpetusRX against keeping their current EMR and adding a checkout layer only.
An operations lead should evaluate the daily workflow: how price comparison works across 20+ pharmacies, how smart routing assigns fulfillment, how rejected orders are surfaced and recovered, and how real-time status reaches patients. A prescriber should evaluate clinical accuracy and speed inside the EMR: whether SIG entry is fast, whether licensure and state routing are handled before submission, and how often a clean order is rejected downstream.